Phase II, Open-Label, Multicenter Trial of Crizotinib in Japanese Patients with Advanced Non-Small Cell Lung Cancer Harboring a MET Gene Alteration: Co-MET Study
International Journal of Clinical Oncology(2024)
Key words
Non-small cell lung cancer,Crizotinib,MET gene alteration,RT-PCR assay,Next-generation sequencing
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined